Baseline dp-ucMGP <3000 N = 24 | Baseline dp-ucMGP >3000 N = 26 | P-value | |
---|---|---|---|
Age (years), median (IQR) | 69.0 (53.5; 76.5) | 73.5 (61.7; 80.0) | 0.28 |
Gender, male n (%) | 17 (70.8) | 13 (50.0) | 0.16 |
Dialysis vintage (months), median (IQR) | 40.0 (17.0; 99.2) | 49.5 (37.7; 119.0) | 0.15 |
Diabetes, n (%) | 11 (45.8) | 7 (26.9) | 0.24 |
Hypertension, n (%) | 18 (75.0) | 20 (76.9) | 1.00 |
Smoking, n (%) | 3 (12.5) | 5 (19.2) | 0.70 |
Calcification score, median (IQR) | 4.5 (1.0; 10.7) | 10.5 (3.7; 15.2) | 0.04 |
NCBB, n (%) | 11 (45.8) | 9 (34.6) | 0.56 |
Residual diuresis, n (%) | 4 (16.7) | 2 (7.7) | 0.41 |
Calcium dose (tablets of 600 mg), median (IQR) | 2.0 (1.0; 3.0) | 1.0 (1.0; 2.0) | 0.10 |
Alfacalcidol dose (μg), median (IQR) | 0.75 (0.00; 1.50) | 0.75 (0.25; 1.50) | 0.69 |
Serum phosphate (mg/dl), median (IQR) | 3.85 (3.50; 5.07) | 3.9 (3.0; 4.5) | 0.20 |
Serum calcium (mg/dl), median (IQR) | 9.0 (8.7; 9.3) | 9.15 (8.90; 9.32) | 0.13 |
PTH (pg/ml), median (IQR) | 158.5 (97.1; 260.2) | 205.0 (126.0; 319.0) | 0.38 |
LDL cholesterol (mg/dl), median (IQR) | 93.5 (77.7; 115.0) | 92.0 (76.0; 113.0) | 0.56 |
BMI (Kg/m2), median (IQR) | 25.57 (22.74; 29.64) | 26.02 (22.76; 28.42) | 0.74 |
URR, median (IQR) | 75.0 (69.5; 78.7) | 75.00 (71.25; 79.25) | 0.76 |
Albumin, median (IQR) | 39.0 (35.2; 41.0) | 38.50 (36.00; 41.25) | 0.99 |
CAD, n (%) | 6 (25.0) | 8 (30.8) | 0.76 |
Cinacalcet, n (%) | 1 (4.2) | 1 (3.8) | 1.00 |
Previous acenocoumadin, n (%) | 3 (12.5) | 3 (11.5) | 1.00 |
PTHX, n (%) | 0 (0.0) | 2 (7.7) | 0.49 |
Recent fracture, n (%) | 0 (0.0) | 3 (11.5) | 0.24 |